e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased expression of epidermal growth factor-receptor in idiopathic interstitial pneumonias. A tissue microarray study
A. Tzouvelekis, E. Tsiambas, A. Karameris, G. Vilaras, P. Tzoumakari, M. Froudarakis, P. Steiropoulos, G. Drakonakis, D. Bouros (Alexandroupolis, Athens, Greece)
Source:
Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Session:
Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Session type:
Thematic Poster Session
Number:
3407
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tzouvelekis, E. Tsiambas, A. Karameris, G. Vilaras, P. Tzoumakari, M. Froudarakis, P. Steiropoulos, G. Drakonakis, D. Bouros (Alexandroupolis, Athens, Greece). Increased expression of epidermal growth factor-receptor in idiopathic interstitial pneumonias. A tissue microarray study. Eur Respir J 2007; 30: Suppl. 51, 3407
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
Source: Eur Respir J 2001; 17: 1220-1227
Year: 2001
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Morphometric study of hypoxia inducible factor-1α-vascular endothelial growth factor (HIF-1α-VEGF) axis in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays
Source: Eur Respir J 2006; 28: Suppl. 50, 338s
Year: 2006
Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Epidermal growth factor in the lungs of infants developing chronic lung disease
Source: Eur Respir J 2001; 18: 796-800
Year: 2001
Simultaneous mRNA expression analysis of transforming growth factor β1 and three types of TGF-β receptors in broncho-alveolar lavage cells from patients with interstitial lung diseases – the pilot study
Source: Eur Respir J 2003; 22: Suppl. 45, 223s
Year: 2003
Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Idiopathic pulmonary fibrosis in relation to the gene polymorphisms of transforming growth factor-beta1 and plasminogen activation inhibitor 1
Source: Eur Respir J 2007; 30: Suppl. 51, 489s
Year: 2007
Pleural fibrosis induced by transforming growth factor (TGF)-β1 gene transfer
Source: Eur Respir J 2005; 26: Suppl. 49, 100s
Year: 2005
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Expression and synthesis of connective tissue growth factor by human γδT-lymphocytes. Effect of interleukin-15 and transforming growth factor-β1
Source: Eur Respir J 2002; 20: Suppl. 38, 213s
Year: 2002
Interdependence of endothelin-1 and transforming growth factor-β
1
on Wnt3a expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions
Source: Eur Respir J 2003; 21: 611-615
Year: 2003
Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept